Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Charles Sande

Dr Charles Sande

Podcast interview

Airway inflammation in early life

Chronic respiratory diseases disproportionately affects young adults in low income settings, particularly when they had been exposed to noxious substances from biomass smoke in early life. Using methods developed to understand airway inflammation caused by viral infections can help us understand the mechanisms underlying this pathology and better devise interventions.

View podcast transcript

Charles Sande

Research scientist

My research focusses on pneumonia and other serious respiratory infections that affect infants and young children. Pneumonia remains a major killer, particularly in the developing world, where the healthcare infrastructure necessary for managing the most serious manifestations of the disease are inadequate. Our group is particularly interested in understanding the mechanisms of disease caused by respiratory infections such as respiratory syncytial virus (RSV) and Streptococcus pneumoniae. To gain a complete understanding of the mechanisms of disease pathology, we use a coordinated systems biology approach to examine in fine detail the interactions between the immune systems of sick children and the pathogens that cause pneumonia. We use a broad array of tools including mass spectrometry-based proteomics, protein microarrays, bacterial metagenomics and RNA-seq transcriptomics to understand host-pathogen interactions in the respiratory tract. Using these techniques we are gaining new insights into the breadth of the infant response to infection and how these responses may be leveraged in the development of effective interventions against pneumonia in the future.

Social media